agilon health, inc.AGLEarnings & Financial Report
agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.
AGL Q1 FY2026 Key Financial Metrics
Revenue
$1.4B
Gross Profit
N/A
Operating Profit
N/A
Net Profit
$49.0K
Gross Margin
N/A
Operating Margin
N/A
Net Margin
0.0%
YoY Growth
-3.0%
agilon health, inc. Q1 FY2026 Financial Summary
agilon health, inc. reported revenue of $1.4B (down 3.0% YoY) for Q1 FY2026, with a net profit of $49.0K (0.0% margin).
Key Financial Metrics
| Total Revenue | $1.4B |
|---|---|
| Net Profit | $49.0K |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q1 FY2026 |
agilon health, inc. Annual Revenue by Year
agilon health, inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $5.9B).
agilon health, inc. Quarterly Revenue & Net Profit History
agilon health, inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.4B | -3.0% | $49.0K | 0.0% |
| Q4 FY2025 | $1.6B | +3.1% | $-188.9M | -12.0% |
| Q3 FY2025 | $1.4B | -1.1% | $-110.2M | -7.7% |
| Q2 FY2025 | $1.4B | -5.9% | $-104.4M | -7.5% |
| Q1 FY2025 | $1.5B | -4.5% | $12.1M | 0.8% |
| Q4 FY2024 | $1.5B | +44.2% | $-105.8M | -6.9% |
| Q3 FY2024 | $1.5B | +27.6% | $-117.6M | -8.1% |
| Q2 FY2024 | $1.5B | +38.7% | $-30.7M | -2.1% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.48B | $1.45B | $1.52B | $1.53B | $1.39B | $1.44B | $1.57B | $1.42B |
| YoY Growth | 38.7% | 27.6% | 44.2% | -4.5% | -5.9% | -1.1% | 3.1% | -3.0% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.16B | $2.09B | $1.73B | $1.93B | $1.71B | $1.60B | $1.27B | $1.50B |
| Liabilities | $1.49B | $1.52B | $1.26B | $1.43B | $1.30B | $1.29B | $1.14B | $1.32B |
| Equity | $676.6M | $574.9M | $471.0M | $500.3M | $408.9M | $306.1M | $126.7M | N/A |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-18.7M | $-7.7M | $16.4M | $-32.0M | $-35.1M | $-18.2M | $-20.5M |